The estimated Net Worth of Sharon Greenlees is at least $35.4 Thousand dollars as of 2 May 2023. Sharon Greenlees owns over 1,017 units of Bristol-Myers Squibb Co stock worth over $35,374 and over the last 3 years Sharon sold BMY stock worth over $0.
Sharon has made over 1 trades of the Bristol-Myers Squibb Co stock since 2023, according to the Form 4 filled with the SEC. Most recently Sharon exercised 1,017 units of BMY stock worth $49,416 on 2 May 2023.
The largest trade Sharon's ever made was exercising 1,017 units of Bristol-Myers Squibb Co stock on 2 May 2023 worth over $49,416. On average, Sharon trades about 339 units every 0 days since 2022. As of 2 May 2023 Sharon still owns at least 728 units of Bristol-Myers Squibb Co stock.
You can see the complete history of Sharon Greenlees stock trades at the bottom of the page.
Sharon's mailing address filed with the SEC is 430 E. 29TH STREET, 14TH FLOOR, NEW YORK, NY, 10016.
Over the last 17 years, insiders at Bristol-Myers Squibb Co have traded over $318,151,721 worth of Bristol-Myers Squibb Co stock and bought 211,503 units worth $6,601,565 . The most active insiders traders include Lamberto Andreotti, James M Cornelius, and Giovanni Caforio. On average, Bristol-Myers Squibb Co executives and independent directors trade stock every 8 days with the average trade being worth of $1,682,720. The most recent stock trade was executed by Cari Gallman on 1 August 2024, trading 1,061 units of BMY stock currently worth $51,554.
The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.
Bristol-Myers Squibb Co executives and other stock owners filed with the SEC include: